Novartis AG (NVS)
137.19
-0.29
(-0.21%)
USD |
NYSE |
Sep 11, 16:00
137.19
0.00 (0.00%)
After-Hours: 16:43
Novartis Gross Profit (TTM) : 40.59B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.59B |
| March 31, 2026 | 40.76B |
| December 31, 2025 | 40.99B |
| September 30, 2025 | 40.95B |
| June 30, 2025 | 40.12B |
| March 31, 2025 | 38.51B |
| December 31, 2024 | 37.27B |
| September 30, 2024 | 35.87B |
| June 30, 2024 | 34.85B |
| March 31, 2024 | 33.64B |
| December 31, 2023 | 32.77B |
| September 30, 2023 | 32.15B |
| June 30, 2023 | 31.24B |
| March 31, 2023 | 32.18B |
| December 31, 2022 | 33.03B |
| September 30, 2022 | 34.55B |
| June 30, 2022 | 36.07B |
| March 31, 2022 | 36.08B |
| December 31, 2021 | 35.78B |
| September 30, 2021 | 35.10B |
| June 30, 2021 | 34.49B |
| March 31, 2021 | 33.37B |
| December 31, 2020 | 33.56B |
| September 30, 2020 | 33.40B |
| June 30, 2020 | 33.29B |
| Date | Value |
|---|---|
| March 31, 2020 | 33.73B |
| December 31, 2019 | 33.07B |
| September 30, 2019 | 32.12B |
| June 30, 2019 | 31.35B |
| March 31, 2019 | 30.77B |
| December 31, 2018 | 30.37B |
| September 30, 2018 | 31.34B |
| June 30, 2018 | 31.80B |
| March 31, 2018 | 32.01B |
| December 31, 2017 | 31.93B |
| September 30, 2017 | 31.34B |
| June 30, 2017 | 31.01B |
| March 31, 2017 | 31.04B |
| December 31, 2016 | 31.00B |
| September 30, 2016 | 31.14B |
| June 30, 2016 | 31.26B |
| March 31, 2016 | 31.44B |
| December 31, 2015 | 32.04B |
| September 30, 2015 | 32.78B |
| June 30, 2015 | 33.53B |
| March 31, 2015 | 34.53B |
| December 31, 2014 | 36.08B |
| September 30, 2014 | 36.42B |
| June 30, 2014 | 36.52B |
| March 31, 2014 | 36.34B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Roche Holding AG | 55.86B |
| AstraZeneca PLC | 44.95B |
| GSK Plc | 32.65B |
| Johnson & Johnson | 66.63B |
| Eli Lilly & Co. | 66.44B |